Wells Fargo & Company Tarsus Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 13,483 shares of TARS stock, worth $412,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,483

Previous 11,874 13.55%

Holding current value

$412,444

Previous $431,000 15.08%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.17 - $38.73 $40,498 - $62,316	1,609 Added 13.55%	13,483 $366,000
Q1 2024 May 10, 2024	BUY	$19.61 - $39.22 $39,435 - $78,871	2,011 Added 20.39%	11,874 $431,000
Q4 2023 Feb 09, 2024	BUY	$12.98 - $20.73 $32,956 - $52,633	2,539 Added 34.67%	9,863 $199,000
Q3 2023 Nov 13, 2023	SELL	$14.75 - $24.62 $34,883 - $58,226	-2,365 Reduced 24.41%	7,324 $130,000
Q2 2023 Aug 15, 2023	BUY	$11.57 - $19.63 $65,706 - $111,478	5,679 Added 141.62%	9,689 $175,000
Q1 2023 May 12, 2023	BUY	$11.92 - $16.27 $12,718 - $17,360	1,067 Added 36.26%	4,010 $50,000
Q4 2022 Feb 13, 2023	SELL	$14.12 - $18.72 $2,301 - $3,051	-163 Reduced 5.25%	2,943 $43,000
Q3 2022 Nov 14, 2022	BUY	$14.08 - $18.5 $858 - $1,128	61 Added 2.0%	3,106 $53,000
Q2 2022 Aug 12, 2022	SELL	$11.08 - $19.08 $18,481 - $31,825	-1,668 Reduced 35.39%	3,045 $45,000
Q1 2022 May 16, 2022	SELL	$14.49 - $24.28 $42,615 - $71,407	-2,941 Reduced 38.42%	4,713 $79,000
Q4 2021 Feb 14, 2022	SELL	$21.21 - $29.68 $45,177 - $63,218	-2,130 Reduced 21.77%	7,654 $172,000
Q3 2021 Nov 15, 2021	BUY	$21.45 - $29.22 $209,866 - $285,888	9,784 New	9,784 $210,000
Q2 2021 Aug 16, 2021	SELL	$27.16 - $38.59 $52,717 - $74,903	-1,941 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$27.37 - $47.25 $34,267 - $59,157	-1,252 Reduced 39.21%	1,941 $63,000
Q4 2020 Feb 09, 2021	BUY	$19.17 - $49.62 $61,209 - $158,436	3,193 New	3,193 $132,000

Others Institutions Holding TARS

# of Institutions

155

Shares Held

40.4M

Call Options Held

37.9K

Put Options Held

808K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $815M
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Tarsus Pharmaceuticals, Inc. Transaction History